Kyle R.Cunnion


Atlanta + 1.404.581.8722

Kyle Cunnion focuses his practice on corporate law, with particular emphasis on M&A, corporate governance, and general corporate matters. He advises public and private companies, as well as private equity firms, on domestic and cross-border M&A, corporate restructurings, strategic investments, and capital raising transactions. Kyle has represented clients from a diverse range of sectors, including venture capital, technology, consumer goods, chemicals, and health care.

Prior to attending law school, Kyle worked as an equity specialist at a global financial analytics firm in New York. While simultaneously attending law school and earning his master's degree, he completed an internship at a North Carolina investment bank that advises clients regarding the financial aspects of sell-side M&A transactions.


  • GRA Venture Fund sells minority interest in AKESOgen to Tempus LabsJones Day represented GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC in connection with the sale of a minority interest in AKESOgen, a provider of premier research services and the highest quality data for scientists doing clinical or basic research across the world, to Tempus Labs.
  • Koch participates in $1.5 billion investment in InforJones Day is advising Koch Equity Development (KED), the acquisition and investment subsidiary of Koch Industries, Inc., in connection with an investment of $1.5 billion in Infor by KED and Golden Gate Capital.
  • Gray Television acquires Raycom Media for $3.6 billionJones Day advised Gray Television, Inc., a television broadcast company headquartered in Atlanta, Georgia, in connection with its acquisition of privately-owned Raycom Media, Inc., a Montgomery, Alabama-based television broadcast company, in a cash and stock transaction with an enterprise value of approximately $3.6 billion.
  • Southern Company sells certain Florida assets to NextEra Energy for $6.5 billionJones Day advised Southern Company in three separate transactions for the sale of several of its Florida assets – Gulf Power Company, Florida City Gas, and the entities holding Southern Power’s interest in Plant Oleander and Plant Stanton – to NextEra Energy (NYSE: NEE) for an aggregate purchase price of $6.5 billion, including total equity value of approximately $5.1 billion.
  • GRA Venture Fund participates in $25 million Series A financing round of Antios TherapeuticsJones Day represented GRA Venture Fund in connection with its participation in the $25 million Series A financing round of Antios Therapeutics Inc., an Atlanta, Georgia-based biopharmaceutical company focused on the development of novel antiviral therapies for unmet medical needs.
  • Foreign investors initiate civil and criminal actions following multimillion embezzlement schemeJones Day represents a group of foreign investors who were victims of a multimillion embezzlement scheme orchestrated by their investment manager.
  • Total, NOVA, Borealis form venture for U.S. Gulf Coast projectsJones Day advised Total Petrochemicals & Refining USA, and affiliates of Austria’s Borealis AG and Canada’s NOVA Chemicals (both affiliates of the UAE’s Mubadala Investment Company) in the formation of a joint venture to build a $1.7 billion, 1 million ton per year ethane cracker in Port Arthur, Texas, acquisition of Total’s existing 400,000 ton per year two-line polyethylene plant in Bayport, Texas, and building of a new 625,000 ton per year Borstar PE plant at the Bayport site.
  • Birch Communications' Cloud and Business Services business acquired by Fusion Telecommunications International, Inc. for $600 millionJones Day advised Birch Communications, Inc. in the acquisition of its cloud and business services business by Fusion Telecommunications International, Inc. for approximately $600 million in an all-stock transaction which included the purchase of 50 million shares of Fusion’s Common Stock and the refinancing of $444 million of Birch indebtedness.
  • GRA Venture Fund invests in AcivilateJones Day represented GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC in connection with its equity investment of series seed stock in Acivilate, Inc., an Atlanta-based tech startup focused on the criminal justice sector.
  • J.M. Huber sells Silica business to Evonik for $630 millionJones Day advised J.M. Huber Corporation in the sale of its Silica business unit of Huber Engineered Materials to Evonik Industries AG for $630 million.
  • Newell Brands sells Winter Sports businesses to Kohlberg & Company for $240 millionJones Day advised Newell Brands Inc. (NYSE: NWL) in the sale of its Winter Sports businesses to private equity firm Kohlberg & Company for $240 million, subject to adjustment.
  • GRA Venture Fund invests in Carbice CorporationJones Day represented GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC in connection with their purchase of Series Seed Preferred Stock in a private placement by Carbice Corporation, a provider of thermal materials.
  • Emrgy raises capital in private placement of Convertible NotesJones Day advised Emrgy Inc., a developer of technologies to deliver distributed energy and efficiency solutions, in connection with the issuance of Convertible Notes in a private placement to certain accredited investors.
  • Jones Day secures guardianship for unaccompanied minors from GuatemalaJones Day recently represented the uncle of two girls, ages 11 and 14, who had emigrated from Guatemala to the United States fleeing hardship and poverty.
  • Morgan Stanley Capital Partners acquires majority interest in Fisher ContainerJones Day advised Morgan Stanley Capital Partners (MSCP) in connection with the acquisition of a majority interest in Fisher Container Holdings, LLC and Fisher Container, LLC, a leading manufacturer of innovative and technical flexible packaging products, by an affiliate of MSCP and experienced plastics and packaging executive, Kevin Keneally.
  • Capital One arranges $534.9 million term loan for acquisition of 34 medical office buildingsJones Day represented Capital One Bank, N.A., as administrative agent, in connection with a $534.9 million term loan used to finance the acquisition of 34 medical office buildings located in 14 states.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.